学习贯彻落实中医药法:两部门赴内蒙古调研中医药法实施情况

2018-06-30 赵丹 中国中医

全国人大教科文卫委人口卫生体育室主任丁巍、国家中医药管理局法监司司长余海洋带队赴内蒙古调研中医药法实施情况。

全国人大教科文卫委人口卫生体育室主任丁巍、国家中医药管理局法监司司长余海洋带队赴内蒙古调研中医药法实施情况。

调研组一行实地察看了内蒙古自治区国际蒙医医院、呼和浩特市蒙医中医医院、赤峰市第二蒙中医医院、宁城县中蒙医医院和赤峰市红山区备案中医诊所,了解中医药法宣传贯彻落实具体情况,听取意见建议。

调研组在呼和浩特市召开华北五省(区、市)中医药法实施情况座谈会,内蒙古、北京、天津、河北、山西等地中医药主管部门汇报了贯彻实施中医药法进展情况,内蒙古自治区人大教科文卫委、人力资源和社会保障厅、食品药品监督管理局介绍了各自部门推动中医药法落实有关情况。

会上,丁巍肯定了各地各部门在贯彻实施中医药法中所做的工作,指出下一步将加强督促国务院各部门、各级政府重视中医药法的贯彻落实,推动配套制度进一步制定完善,注重发挥好中医药法在鼓励社会办医、促进中医药质量管理、推动中医药在基层发挥好作用等方面的作用,并将积极推动中医药法纳入全国人大常委会执法检查项目,加大对中医药法贯彻落实的监督力度。

国家中医药管理局法监司、国合司相关工作人员,部分省市中医药管理局代表及专家参加调研。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1675430, encodeId=59c216e5430fa, content=<a href='/topic/show?id=a0542111129' target=_blank style='color:#2F92EE;'>#两部门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21111, encryptionId=a0542111129, topicName=两部门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f827226538, createdName=日月, createdTime=Fri Feb 01 05:54:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656326, encodeId=53ee16563263b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Thu Nov 29 12:54:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751458, encodeId=9bec1e51458bd, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 21 08:54:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898735, encodeId=4eef1898e3584, content=<a href='/topic/show?id=e12930529ee' target=_blank style='color:#2F92EE;'>#内蒙古#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30529, encryptionId=e12930529ee, topicName=内蒙古)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Dec 07 09:54:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409603, encodeId=de5d1409603fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 02 00:54:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328491, encodeId=e87d328491dc, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Jul 01 15:23:29 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328216, encodeId=c30f328216af, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jun 30 12:33:43 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328202, encodeId=84d8328202af, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jun 30 11:26:06 CST 2018, time=2018-06-30, status=1, ipAttribution=)]
    2019-02-01 日月
  2. [GetPortalCommentsPageByObjectIdResponse(id=1675430, encodeId=59c216e5430fa, content=<a href='/topic/show?id=a0542111129' target=_blank style='color:#2F92EE;'>#两部门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21111, encryptionId=a0542111129, topicName=两部门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f827226538, createdName=日月, createdTime=Fri Feb 01 05:54:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656326, encodeId=53ee16563263b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Thu Nov 29 12:54:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751458, encodeId=9bec1e51458bd, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 21 08:54:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898735, encodeId=4eef1898e3584, content=<a href='/topic/show?id=e12930529ee' target=_blank style='color:#2F92EE;'>#内蒙古#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30529, encryptionId=e12930529ee, topicName=内蒙古)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Dec 07 09:54:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409603, encodeId=de5d1409603fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 02 00:54:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328491, encodeId=e87d328491dc, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Jul 01 15:23:29 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328216, encodeId=c30f328216af, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jun 30 12:33:43 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328202, encodeId=84d8328202af, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jun 30 11:26:06 CST 2018, time=2018-06-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1675430, encodeId=59c216e5430fa, content=<a href='/topic/show?id=a0542111129' target=_blank style='color:#2F92EE;'>#两部门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21111, encryptionId=a0542111129, topicName=两部门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f827226538, createdName=日月, createdTime=Fri Feb 01 05:54:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656326, encodeId=53ee16563263b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Thu Nov 29 12:54:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751458, encodeId=9bec1e51458bd, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 21 08:54:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898735, encodeId=4eef1898e3584, content=<a href='/topic/show?id=e12930529ee' target=_blank style='color:#2F92EE;'>#内蒙古#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30529, encryptionId=e12930529ee, topicName=内蒙古)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Dec 07 09:54:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409603, encodeId=de5d1409603fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 02 00:54:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328491, encodeId=e87d328491dc, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Jul 01 15:23:29 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328216, encodeId=c30f328216af, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jun 30 12:33:43 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328202, encodeId=84d8328202af, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jun 30 11:26:06 CST 2018, time=2018-06-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1675430, encodeId=59c216e5430fa, content=<a href='/topic/show?id=a0542111129' target=_blank style='color:#2F92EE;'>#两部门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21111, encryptionId=a0542111129, topicName=两部门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f827226538, createdName=日月, createdTime=Fri Feb 01 05:54:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656326, encodeId=53ee16563263b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Thu Nov 29 12:54:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751458, encodeId=9bec1e51458bd, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 21 08:54:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898735, encodeId=4eef1898e3584, content=<a href='/topic/show?id=e12930529ee' target=_blank style='color:#2F92EE;'>#内蒙古#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30529, encryptionId=e12930529ee, topicName=内蒙古)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Dec 07 09:54:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409603, encodeId=de5d1409603fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 02 00:54:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328491, encodeId=e87d328491dc, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Jul 01 15:23:29 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328216, encodeId=c30f328216af, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jun 30 12:33:43 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328202, encodeId=84d8328202af, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jun 30 11:26:06 CST 2018, time=2018-06-30, status=1, ipAttribution=)]
    2018-12-07 xugumin
  5. [GetPortalCommentsPageByObjectIdResponse(id=1675430, encodeId=59c216e5430fa, content=<a href='/topic/show?id=a0542111129' target=_blank style='color:#2F92EE;'>#两部门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21111, encryptionId=a0542111129, topicName=两部门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f827226538, createdName=日月, createdTime=Fri Feb 01 05:54:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656326, encodeId=53ee16563263b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Thu Nov 29 12:54:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751458, encodeId=9bec1e51458bd, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 21 08:54:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898735, encodeId=4eef1898e3584, content=<a href='/topic/show?id=e12930529ee' target=_blank style='color:#2F92EE;'>#内蒙古#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30529, encryptionId=e12930529ee, topicName=内蒙古)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Dec 07 09:54:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409603, encodeId=de5d1409603fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 02 00:54:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328491, encodeId=e87d328491dc, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Jul 01 15:23:29 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328216, encodeId=c30f328216af, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jun 30 12:33:43 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328202, encodeId=84d8328202af, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jun 30 11:26:06 CST 2018, time=2018-06-30, status=1, ipAttribution=)]
    2018-07-02 cathymary
  6. [GetPortalCommentsPageByObjectIdResponse(id=1675430, encodeId=59c216e5430fa, content=<a href='/topic/show?id=a0542111129' target=_blank style='color:#2F92EE;'>#两部门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21111, encryptionId=a0542111129, topicName=两部门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f827226538, createdName=日月, createdTime=Fri Feb 01 05:54:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656326, encodeId=53ee16563263b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Thu Nov 29 12:54:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751458, encodeId=9bec1e51458bd, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 21 08:54:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898735, encodeId=4eef1898e3584, content=<a href='/topic/show?id=e12930529ee' target=_blank style='color:#2F92EE;'>#内蒙古#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30529, encryptionId=e12930529ee, topicName=内蒙古)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Dec 07 09:54:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409603, encodeId=de5d1409603fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 02 00:54:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328491, encodeId=e87d328491dc, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Jul 01 15:23:29 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328216, encodeId=c30f328216af, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jun 30 12:33:43 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328202, encodeId=84d8328202af, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jun 30 11:26:06 CST 2018, time=2018-06-30, status=1, ipAttribution=)]
    2018-07-01 大爰

    学习并分享!!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1675430, encodeId=59c216e5430fa, content=<a href='/topic/show?id=a0542111129' target=_blank style='color:#2F92EE;'>#两部门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21111, encryptionId=a0542111129, topicName=两部门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f827226538, createdName=日月, createdTime=Fri Feb 01 05:54:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656326, encodeId=53ee16563263b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Thu Nov 29 12:54:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751458, encodeId=9bec1e51458bd, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 21 08:54:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898735, encodeId=4eef1898e3584, content=<a href='/topic/show?id=e12930529ee' target=_blank style='color:#2F92EE;'>#内蒙古#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30529, encryptionId=e12930529ee, topicName=内蒙古)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Dec 07 09:54:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409603, encodeId=de5d1409603fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 02 00:54:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328491, encodeId=e87d328491dc, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Jul 01 15:23:29 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328216, encodeId=c30f328216af, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jun 30 12:33:43 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328202, encodeId=84d8328202af, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jun 30 11:26:06 CST 2018, time=2018-06-30, status=1, ipAttribution=)]
    2018-06-30 三生有幸9135

    学习一下

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1675430, encodeId=59c216e5430fa, content=<a href='/topic/show?id=a0542111129' target=_blank style='color:#2F92EE;'>#两部门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21111, encryptionId=a0542111129, topicName=两部门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f827226538, createdName=日月, createdTime=Fri Feb 01 05:54:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656326, encodeId=53ee16563263b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Thu Nov 29 12:54:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751458, encodeId=9bec1e51458bd, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 21 08:54:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898735, encodeId=4eef1898e3584, content=<a href='/topic/show?id=e12930529ee' target=_blank style='color:#2F92EE;'>#内蒙古#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30529, encryptionId=e12930529ee, topicName=内蒙古)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Dec 07 09:54:00 CST 2018, time=2018-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409603, encodeId=de5d1409603fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 02 00:54:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328491, encodeId=e87d328491dc, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Jul 01 15:23:29 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328216, encodeId=c30f328216af, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jun 30 12:33:43 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328202, encodeId=84d8328202af, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jun 30 11:26:06 CST 2018, time=2018-06-30, status=1, ipAttribution=)]
    2018-06-30 天地飞扬

    了解一下.谢谢分享!

    0

相关资讯

国医馆数量井喷,3大吸金模式曝光

《中医药法》颁布实施之后,由于政策层面对社会办中医的大力支持,无论是大面积经营的国医馆,还是小面积运营的中医诊所,发展都进入了井喷期。

中医药法实施一周年:老百姓获得感不断增强,中医药事业进入依法振兴发展新时代

“依法支持中医药事业发展”,2017年政府工作报告中,短短11字力透纸背。法律的生命力在于实施,法律的权威也在于实施。2018年7月1日是中医药法实施一周年的日子。这部承载了几代人期待的中医药综合性法律,自进入立法议程之始,就肩负着推动中医药事业振兴发展的光荣使命。如今,中医药法实施已近一周年,这部立得住、行得通、用得上的法律,让人们切实地感受到它给中医药行业带来的深刻变革。

福建举办学习中医药法知识竞赛决赛

5月4日,由福建省卫生计生委、福建省总工会主办,福州市中医院承办的“2018年全省学习中医药法知识竞赛”决赛在福州举办。全省共33个代表队,99位选手进入现场决赛,最终平潭综合实验区卫生计生局代表队夺得桂冠,尤溪县中医医院、泉州市正骨医院代表队获二等奖,福州市卫生计生委、龙岩市中医院、晋江市中医院代表队获三等奖。

马建中赴贵州调研中医药法实施情况

6月13~15日,国家中医药管理局副局长马建中带队赴贵州调研中医药法实施情况,深入贵阳市息烽县中医医院、遵义市中医医院及社区卫生服务机构,并专程到备案的中医诊所了解相关情况、听取建议。

闫树江在陕西调研中医药法实施情况

国家中医药管理局副局长闫树江前往陕西调研中医药法实施情况并与相关人员座谈。座谈会上, 西北及东北地区8省(区)中医药管理部门负责人汇报了本省中医药法执行情况,陕西省人大、法制办、卫生计生委、食药监局以及西安、铜川等地中医药管理部门、中医医疗机构、备案中医诊所、中医确有专长人员等围绕中医药法实施,提出意见及建议。

全国中医医政工作会召开:扎实做好中医药法实施工作

2018年全国中医医政工作会议暨改善医疗服务工作经验交流会在京召开。会议肯定了2017年及十八大以来的中医医政工作,部署2018年重点工作。